Related by context. All words. (Click for frequent words.) 68 Molecular Insight 67 Nventa 67 ProLindac TM 66 Sunesis Pharmaceuticals 66 Relypsa 65 Dynogen 65 Æterna Zentaris 65 Ziopharm 65 Neil K. Warma 64 Clavis Pharma 64 Corautus 64 PharmaFrontiers 64 WILEX 64 PsychoGenics 64 IDM Pharma 64 Tovaxin 64 ESBATech 64 ganetespib 64 Daniel Junius 64 Ardea Biosciences 64 Innovive 64 OXiGENE 64 Hana Biosciences 64 Gemin X 64 Celator 64 Alfacell 64 EntreMed 64 omacetaxine 64 Novelos 64 AVEO 64 Harbor BioSciences 63 Aegerion 63 Excaliard 63 ARIAD 63 Aegera Therapeutics 63 Neuraltus 63 FoldRx 63 AspenBio 63 Ceregene 63 Response Genetics 63 PEG SN# 63 Vion Pharmaceuticals 63 Anthera 63 bardoxolone 63 ARIUS 63 Peregrine Pharmaceuticals 63 Harry Palmin President 63 Anacor 63 Micromet 63 phase IIa clinical 63 InNexus 63 Chemokine 63 Pacira 63 Anaphore 63 Santhera 63 ISIS # 63 Corcept 63 Neose 63 Tolerx 63 Numoda 63 Vaccinex 62 Adherex 62 TRO# 62 KYTHERA 62 Idenix 62 Nasdaq MBRX announced 62 MIGENIX 62 Metaphore 62 NovaDel 62 Incyte 62 AEterna 62 Rexahn Pharmaceuticals 62 Aastrom 62 Synta Pharmaceuticals 62 Syndax 62 Receptos 62 Neurologix 62 Delcath Systems 62 Lpath 62 AP# [003] 62 Enzon 62 Galenea 62 Bicifadine 62 NOXXON 62 XTLbio 62 Juergen Engel Ph.D. 62 Altus Pharmaceuticals 62 SEQUENOM 62 Archexin 62 Sym# 62 Can Fite 62 CRLX# 62 Neurobiological Technologies 62 Mr. Bentsur 62 Repros 62 Resolvyx 62 Emisphere Technologies 62 Cleveland BioLabs 62 Versartis 62 Mr. Kriegsman 62 Power3 Medical 62 Curon Medical 62 EnzymeRx 62 phase IIb clinical 62 Azedra 62 Keryx Biopharmaceuticals 62 Alnara 62 Oncolin 61 KineMed 61 Arqule 61 NASDAQ BPAX 61 Adventrx 61 GRNVAC1 61 QuatRx 61 Fibrocell Science 61 Tranzyme 61 TargeGen 61 InSite Vision 61 NASDAQ LGND 61 Ophthotech 61 CR# vcMMAE 61 Aerovance 61 Thallion 61 PXD# 61 INCB# [001] 61 Pluristem 61 Phase Ib II 61 Genitope Corporation 61 Myrexis 61 CEQ# 61 VIRxSYS 61 ImmunoCellular 61 Transave 61 Tovaxin ® 61 Chemokine Therapeutics 61 NovaBay 61 RGB # 61 Athersys 61 Resverlogix 61 HQK 61 phase IIb 61 atacicept 61 MaxCyte 61 Pervasis 61 SCOLR Pharma 61 Poniard Pharmaceuticals 61 Opexa Therapeutics Inc. 61 NASDAQ AVEO 61 Palatin Technologies 61 EnVivo 61 CorMedix 61 Phenomix 61 obatoclax 61 Oxxon 61 Tarvacin TM 61 NASDAQ OPXA 61 Metabasis Therapeutics Inc. 61 Intellikine 61 EyeGate Pharma 61 Plexxikon 61 Symadex 61 BDSI 61 Phase Ib study 61 Biolex 61 Halozyme Therapeutics 61 OXi# 61 Aeolus Pharmaceuticals 61 TOPIGEN 61 TOCOSOL Paclitaxel 61 IMA# 61 Halozyme 61 Inhibitex 61 Dr. Fahar Merchant 61 Virulizin ® 61 Azedra TM 61 Furiex 61 OncoVEX 60 XTENT 60 BioMS 60 Dicerna 60 CombinatoRx 60 Omthera 60 Amorcyte 60 Hollis Eden 60 ImmunoGen 60 Alzhemed TM 60 FOLOTYN ® 60 Delcath 60 Juvaris 60 Spectrum Pharmaceuticals 60 Protalex 60 OncoVEX GM CSF 60 Urigen 60 Kiadis Pharma 60 sapacitabine 60 Incara 60 Cerimon 60 Sernova 60 zanolimumab 60 Biotie 60 SANUWAVE 60 Miravant 60 Guanilib 60 Hybridon 60 Onconova 60 Adenosine Therapeutics 60 Dr. Aiping Young 60 VentiRx 60 Ascenta Therapeutics 60 Phase IIB 60 Regeneron Pharma 60 MOZOBIL 60 Auxilium Pharmaceuticals 60 Progenics Pharmaceuticals 60 BioNumerik 60 TapImmune 60 ZIOPHARM 60 immatics 60 OHR/AVR# 60 Salmedix 60 Virulizin R 60 Spiro Rombotis President 60 Karo Bio 60 Glufosfamide 60 Dr. Yatscoff 60 VEGF Trap 60 Sunesis 60 Cascade LifeSciences 60 Myocet 60 BioMarck 60 Factor VIIa 60 telomerase therapeutic 60 Alseres 60 PHX# 60 Inflazyme 60 Georges Gemayel 60 Addex 60 Mersana 60 glucokinase activator 60 romidepsin 60 ImaRx 60 Phase #b/#a clinical 60 Semafore 60 alvespimycin 60 Daclizumab 60 Exelixis 60 eResearchTechnology 60 GRN# 60 Aeterna Zentaris 60 Scancell 60 Innovive Pharmaceuticals 60 Intarcia 60 Molecular Biometrics 60 EyeGate 60 NovaBay Pharmaceuticals 60 Aegera 60 Metabolex 60 NeuroMedix 60 Naurex 60 MacroChem 60 vosaroxin 60 Xcyte 60 Nasdaq OPTR 60 AMEX RGN 60 Mipomersen 60 Zosano 60 Bionovo 60 Akesis 60 Nasdaq INHX 60 AVEO Pharmaceuticals 60 AVANIR 60 Arno Therapeutics 60 CGEN # 60 Gentium 60 Metabasis Therapeutics 60 BioMS Medical 60 Phase Ib 60 Ceflatonin R 60 Sopherion 59 Nasdaq RDEA 59 AcelRx 59 Nasdaq ENZN 59 FluoroPharma 59 Medgenics 59 Regado Biosciences 59 Pharmos 59 Cell Genesys 59 MultiCell Technologies 59 Cytokinetics Incorporated NASDAQ CYTK 59 Lexicon Pharmaceuticals 59 eniluracil 59 Neuro Hitech 59 NeoGenomics 59 EOquin TM 59 OvaRex R 59 Neurogen 59 EGEN 59 SCYNEXIS 59 Plicera 59 Allovectin 7 59 Ciphergen 59 NanoViricides 59 BioDelivery Sciences 59 3SBio 59 Cethrin 59 metaglidasen 59 Annamycin 59 DPX Survivac 59 Fibrocell 59 COTI 59 Dynavax 59 MacuSight 59 oral taxane 59 NASDAQ ARIA 59 Phase IIa trials 59 Curaxin 59 Ligand Pharmaceuticals Incorporated 59 Addrenex 59 HuMax CD4 59 J. Mazzo Ph.D. 59 ONCONASE 59 Neoprobe 59 Proteo 59 Barry D. Quart 59 PSN# [002] 59 Avalon Pharmaceuticals 59 XOMA 59 mertansine 59 SAR# [004] 59 Mesoblast 59 Ron Bentsur 59 Quinamed 59 Orexo 59 Pharmasset 59 MEK inhibitor RDEA# 59 Antigenics 59 JAK inhibitor 59 Isotechnika 59 preclinical efficacy 59 NASDAQ ARRY 59 lomitapide 59 Nasdaq VRTX 59 Cytori Therapeutics NASDAQ CYTX 59 JAK1 59 Jennerex 59 Aplidin 59 Akesis Pharmaceuticals 59 RhuDex 59 AVN# [001] 59 ANAVEX 59 Protox 59 AeroLEF TM 59 Curagen 59 Diatos 59 therapeutic monoclonal antibodies 59 Auxilium Pharma 59 Aspreva 59 Pharmion Corporation 59 Tavocept 59 Neogenix 59 CoTherix 59 Diamyd 59 Oxigene 59 Advanced Magnetics 59 Phase IIIb clinical 59 BioSeek 59 VitiGam 59 Tuan Ha Ngoc 59 Nasdaq PGNX today 59 huC# DM4 59 Repligen Corporation 59 Nasdaq INCY 59 Synta 59 PhaseBio 59 Metabasis 59 Fodosine 59 VistaGen 59 oral ridaforolimus 59 Ambrx 59 Logical Therapeutics 59 JAK inhibitors 59 Stressgen 59 Oramed 59 Avanir 59 Trubion Pharma 59 anticancer compound 59 EndoTAG TM -1 59 PRTX 59 Enobia 59 Geron Corporation 59 tubulin inhibitor 59 Symphogen 59 AVEO Pharmaceuticals Inc. 59 EpiCept 59 Isotechnika Pharma 59 OncoSec 59 Oasmia 59 Phase Ib clinical 59 Sulonex TM 59 Lycera 59 Ore Pharmaceuticals 59 MAGE A3 ASCI 59 PLK1 SNALP 59 HuMax EGFr 59 Phase IIb trials 59 Icagen 59 tramiprosate Alzhemed TM 59 GammaCan 59 Dacogen injection 59 Welichem 59 Diasome 59 AVAX 59 Phase IIb clinical trials 59 SYGNIS 59 SUCCEED trial 59 CytRx 58 Celsion Corporation 58 BioGeneriX 58 Ligand 58 vascular disrupting agents 58 Protexia R 58 ViaCyte 58 Epiphany Biosciences 58 Proteolix 58 Paul Laikind 58 Fibrillex TM 58 Osiris Therapeutics 58 Robert L. Bratzler 58 ExonHit 58 Phase IIa clinical 58 PROSTVAC TM 58 NeuroSolutions 58 Trofex TM 58 Genaera Corporation 58 bluebird bio 58 Onco TCS 58 INT# [002] 58 Ilypsa 58 Panacos 58 DELEX 58 OrthoLogic 58 preclinical 58 rALLy clinical trial 58 Novelos Therapeutics 58 EndoTAG 58 CardioVascular BioTherapeutics Inc. 58 SciClone Pharmaceuticals 58 Mr. Armando Anido 58 Elusys 58 rxRNA 58 OvaRex ® MAb 58 Memryte 58 forodesine 58 Alocrest 58 Elisabeth Lindner CEO 58 TRACON Pharmaceuticals 58 R#/MEM # 58 TransMolecular 58 Nasdaq PCYC 58 ENMD # 58 Tesmilifene 58 Lorus 58 Tobira Therapeutics 58 Immunomedics Inc. 58 OGeS 58 Steven B. Ratoff 58 Catabasis 58 Opexa Therapeutics 58 elotuzumab 58 Oxford BioMedica 58 SuperGen 58 Chrysalin 58 Anadys Pharmaceuticals 58 vidofludimus 58 NASDAQ LIPD 58 Calistoga Pharmaceuticals 58 Igeneon 58 Lorus Therapeutics 58 ChemoCentryx 58 Bioheart Inc. 58 Lixivaptan 58 Nasdaq ALXN 58 Genelabs 58 Ventrus 58 enzastaurin 58 Cylene 58 HCV protease inhibitor 58 BioAxone 58 Affymax 58 CardioTech 58 ThromboGenics 58 Aegerion Pharmaceuticals 58 Kirsten Drejer 58 PDE4 inhibitor 58 PDX pralatrexate 58 Myriad Pharmaceuticals 58 Tesetaxel 58 HuMax CD# 58 deforolimus 58 ENZON 58 PRAECIS 58 NWBO 58 SARcode Corporation 58 ImmunoVEX HSV2 58 Cloretazine ® 58 CCR9 antagonist 58 Synergy Pharmaceuticals 58 Incyte Corporation 58 Adolor Corporation 58 targeting CD# 58 Ocrelizumab 58 PRT# 58 Nasdaq PPHM 58 HGS ETR1 58 Targeted Chemotherapy 58 AlphaRx 58 Syntonix 58 IL# PE#QQR 58 TetraLogic 58 AMD# [003] 58 GRN#L 58 Edward Lanphier Sangamo 58 Dr. Cauwenbergh 58 InNexus Biotechnology 58 BioMarin 58 KNS # 58 DARA BioSciences 58 Furiex Pharmaceuticals 58 Omni Bio 58 ONCONASE R 58 cannabinor 58 Cardioxyl 58 Atiprimod 58 BAY #-# 58 cabozantinib 58 CombinatoRx Incorporated NASDAQ CRXX 58 MediGene 58 ActivBiotics 58 Revotar 58 XL# XL# XL# 58 Protalex Inc. 58 RenaMed 58 Expression Genetics 58 Enzon Pharmaceuticals 58 Safi Bahcall Ph.D. 58 GED aPC 58 Nasdaq IDRA today 58 rALLy trial 58 Jacob Inbar 58 Archemix 58 Inc. Nasdaq ICGN 58 BiPar 58 ponatinib 58 carfilzomib 58 NASDAQ PCYC 58 ACLARA 58 selective androgen receptor modulator 58 MBRX 58 INCB# [002] 58 Proxinium TM 58 investigational pan BCR 58 Agennix 58 CardioVascular BioTherapeutics 58 Trophos 58 AEterna Zentaris 58 Active Biotech 58 Phase 2a 58 SARcode 58 Pluristem Therapeutics 58 PRNewswire FirstCall Pharmasset 58 Cytochroma 58 Indaflex TM 58 DiObex 58 CoMentis 58 Response Genetics Inc. 58 Litx 58 Delenex 58 Hedgehog antagonist 58 Idera Pharmaceuticals 58 Biovest 58 ImmunoCellular Therapeutics 58 leading oral taxane 58 trastuzumab DM1 T DM1 58 Cempra 58 CAMPATH 58 Provectus Pharmaceuticals 58 Otonomy 58 SPIRIT IV 58 elacytarabine 58 davunetide intranasal AL 58 Merrimack Pharmaceuticals 58 Nastech Pharmaceutical Company 58 Celladon Corporation 58 Cytopia 58 ImmuneRegen BioSciences Inc. 58 Taligen 58 Achillion 58 Dr. Siegall 58 HepaLife 58 Medidur FA 58 midstage trials 58 GlycoMimetics 58 tesmilifene 58 Phase IIa 58 IRX Therapeutics 58 BiTE antibody 58 QRxPharma 58 PANVAC VF 58 Viropro 58 Acologix 58 Enzo Therapeutics 58 DermTech 58 Sunesis Pharmaceuticals Inc. 58 Axentis Pharma 58 Euthymics 58 OncoGenex Pharmaceuticals Inc. 58 Troxatyl 58 ATL/TV# 58 seliciclib CYC# 58 pralatrexate 58 Traficet EN 58 Vernalis plc 58 Dr. Pingpank 57 Poniard 57 Aldagen 57 midstage clinical 57 Cytogen 57 Omacetaxine 57 Tragara Pharmaceuticals Inc. 57 NASDAQ BMTI 57 Cellerant 57 MacroPore Biosurgery 57 Yves Rosconi President 57 AEGR 57 Corgentech 57 Jeffrey H. Buchalter 57 Zonagen 57 FoldRx Pharmaceuticals Inc. 57 AMEX ONI 57 Array BioPharma 57 DXL# 57 Ligand Pharmaceuticals 57 CBLC# 57 OncoGel 57 Removab 57 AMEX DDD 57 multicenter Phase II 57 Cloretazine R 57 Bayhill Therapeutics 57 UVIDEM 57 Tikvah Therapeutics 57 L BLP# 57 MGCD# [001] 57 Pimavanserin 57 Nasdaq FURX 57 LibiGel Phase III 57 Tapestry Pharmaceuticals 57 NASDAQ OSIR 57 Optimer Pharmaceuticals 57 Civacir 57 Lipoxen 57 Sirona Biochem 57 OMRIX 57 Lipid Sciences 57 InteKrin 57 alvimopan 57 Bio Path 57 ASGT 57 Aradigm 57 FermaVir 57 Drew Fromkin President 57 Panzem R NCD 57 JAK2 inhibitor 57 CA9 SCAN 57 Northwest Biotherapeutics 57 Procyon Biopharma 57 SciClone Pharmaceuticals Inc. 57 Threshold Pharmaceuticals 57 Alimera 57 Nasdaq INCY announced 57 RhuDex ® 57 PAION 57 Portola Pharmaceuticals 57 Idenix Pharmaceuticals 57 ANAVEX #-# [003] 57 Callisto Pharmaceuticals 57 Epizyme 57 PREOS R 57 Seattle Genetics SGEN 57 HaptoGuard 57 PDE# inhibitors 57 Optimer 57 torezolid phosphate 57 Pressure BioSciences 57 Phase 1b clinical trials 57 GALNS 57 Phase #b/#a 57 nonclinical studies 57 relapsed multiple myeloma 57 CancerGuide 57 Cloretazine R VNP#M 57 Rigel Pharmaceuticals 57 NYSE Amex PTN 57 Xcellerated T Cells 57 Cyclacel Pharmaceuticals 57 BioLife Solutions 57 Neuradiab 57 talactoferrin 57 ImmuneRegen BioSciences 57 Helix BioMedix 57 NASDAQ OPTR 57 AspenBio Pharma 57 Nasdaq ISIS 57 CCX# 57 Phase 2a clinical 57 YM BioSciences 57 VASTox 57 ProtoKinetix 57 ARYx 57 BioWa 57 Aflibercept 57 CA4P 57 Manja Bouman CEO 57 IntraBiotics 57 Inc. Nasdaq TNGN 57 Ceflatonin 57 Hydra Biosciences 57 XmAb# 57 OXIS 57 Genta Incorporated OTCBB GETA 57 Threshold Pharmaceuticals Inc. 57 Cogane 57 Syrrx 57 Alethia Biotherapeutics 57 collaborator Genentech 57 Cortex Pharmaceuticals 57 ATL# [001] 57 ospemifene 57 Miikana Therapeutics 57 Eximias Pharmaceutical Corporation 57 radiation sensitizer 57 Alligator Bioscience 57 Angioblast 57 pradefovir 57 ANG# 57 NASDAQ OGXI 57 NASDAQ CLDX 57 isoform selective 57 Microbia 57 Acceleron 57 Avila Therapeutics 57 Dr. Scangos 57 Celldex 57 RIGScan CR 57 novel peptides 57 #/#/# Cytokinetics Incorporated 57 PRNewswire FirstCall Exelixis 57 phase 2a 57 HCD# [002] 57 pan HDAC inhibitor 57 BRIM2 57 PSMA ADC 57 TBC# 57 Kahalalide F 57 Xencor 57 Sucampo Pharmaceuticals 57 Apricus Bio 57 TSX VENTURE URO 57 AVRX 57 Sigma Tau Pharmaceuticals 57 XL# XL# 57 IRX 2 57 HORIZONS AMI 57 TOLAMBA 57 AEG# 57 radezolid 57 NASDAQ INGN 57 AMPAKINE CX# 57 Nasdaq ARRY 57 Amorfix 57 InVivo 57 Kleanthis G. Xanthopoulos Ph.D. 57 Regenicin 57 enGene 57 AtheroNova 57 OncoGenex 57 RNA interference RNAi therapeutics 57 Targanta 57 Teflaro 57 BrachySil TM 57 CobaCyte 57 Elixir Pharmaceuticals 57 Ortec 57 Idun Pharmaceuticals 57 NovImmune 57 NASDAQ ALNY 57 Reata Pharmaceuticals 57 AQ4N 57 Xanafide 57 Hoyoung Huh 57 MabCure 57 Ostabolin C 57 preclinically 57 ORTHOCON 57 registrational 57 RDEA 57 CeNeS 57 Charlesson 57 Phytomedics Inc. 57 entinostat 57 Regulus Therapeutics 57 TolerRx 57 Zelos Therapeutics 57 BioAlliance Pharma 57 Encorium 57 Phase IIb III 57 brivaracetam 57 Apexigen 57 ProSavin 57 Epitomics 57 TASKi2 57 Creabilis Therapeutics 57 Serenex 57 Tigris Pharmaceuticals 57 Inc. Nasdaq SGEN 57 huN# DM1 57 Akela Pharma 57 KRN# 57 Amrubicin 57 Morphotek 57 Alexis Borisy President 57 Emisphere Technologies Inc. 57 Ceragenix 57 Immune Response Corporation 57 inVentiv 57 TARIS 57 PEG PAL 57 pharmacokinetic PK study 57 Alantos 57 CDP# 57 NeuroDiscovery 57 Apthera 57 Surface Logix 57 Memgen 57 Ampio 57 multicenter Phase 57 ChemGenex 57 Protalix 57 highly selective adenosine 57 Nuon Therapeutics 57 Cardioxyl Pharmaceuticals 57 NASDAQ CYTK announced 57 NASDAQ SGEN 57 Phase 1b 57 AnaptysBio 57 Phase #/#a 57 Aquinox 57 ENMD 57 Nanobody ® 57 PRECISE trial 57 NYSE Amex ANX 57 Kuslima Shogen 57 clinical pharmacology studies 57 Bioject 57 ISTO 57 Mpex 57 Photocure 57 tiapamil 57 Genome Therapeutics 57 Canvaxin 57 targeted radiotherapeutic 57 daclizumab 57 Graffinity 57 NP2 Enkephalin 57 ProFibrix 57 DR Cysteamine 57 Chemophase 57 ocrelizumab 57 Lux Biosciences 57 OTCBB PYTO 57 Lauren Silvernail 57 Cerimon Pharmaceuticals Inc. 57 Ventrus Biosciences 57 Leuchemix 57 MiddleBrook Pharmaceuticals 57 IDEV 57 PRX# 57 Calando 57 Nasdaq MAPP 57 tesetaxel 57 Alnylam 57 Vegenics 57 HGS# 57 Cabrellis 57 Anticalin R 57 Triolex 57 Kathleen Danenberg 56 AMEX INO 56 Phase 2b trial 56 Exherin TM 56 Romidepsin 56 LibiGel ® 56 NEUVENGE 56 Perifosine 56 dacetuzumab 56 GLP toxicology studies 56 Inclinix 56 Axonyx 56 JP-#/fipamezole 56 Neotropix 56 Dino Dina 56 Serdaxin 56 iroxanadine 56 oncology therapeutics 56 RXi 56 Phase 1a clinical 56 Cellegy 56 YONDELIS 56 ATL# [002] 56 OncoGenex Pharmaceuticals 56 liposomal formulation 56 Immunogen 56 HuMax TAC 56 Friedreich Ataxia FRDA 56 amrubicin 56 Phase IIa trial 56 TKM ApoB 56 GVAX ® 56 JAK3 56 TELCYTA 56 Nasdaq SNSS 56 Presidio Pharmaceuticals 56 CRMD# 56 DRAXIS 56 Panzem 56 SCHWARZ PHARMA 56 tafamidis 56 bafetinib 56 prostone 56 ChondroGene 56 Mr. Bienaime 56 Ardea Biosciences Inc. 56 bazedoxifene 56 NASDAQ CYTX 56 MEK inhibitors 56 Intellect Neurosciences 56 LymphoStat B 56 Jerini 56 Trofex 56 picoplatin 56 Gregory D. Casciaro 56 MacroMed 56 Curis 56 CALGB # [002] 56 Lupuzor 56 Bezielle 56 Maxim Pharmaceuticals 56 Agios Pharmaceuticals 56 ganaxolone 56 Agenus 56 teduglutide 56 CYCLOSET 56 ApoB SNALP 56 TACI Ig 56 glufosfamide 56 Onconase 56 TEMSO 56 talabostat 56 Inc. Nasdaq EXEL 56 Addrenex Pharmaceuticals 56 Jean Jacques Bienaime 56 methylnaltrexone 56 EndoTAG TM 56 AngioChem 56 CIMZIA ™ 56 anticoagulant reversing agent 56 Alton Boynton 56 EntreMed Inc. 56 Apricus Biosciences 56 Radient Pharma 56 Clay B. Siegall 56 Viprinex 56 Immunovaccine 56 Anthony Giovinazzo 56 Accentia Biopharmaceuticals 56 Icatibant 56 Tod Woolf Ph.D. 56 Nasdaq IDRA 56 Desmoteplase 56 Cutanea Life Sciences 56 Nasdaq SGEN 56 SR Pharma 56 Illumigen 56 ENZN 56 BMSN 56 StromaCel 56 IMMU 56 Ablynx 56 TKM PLK1